Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
Clinical trial NCT00561912 · TERMINATED
Trial details
- NCT number
- NCT00561912
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-11-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.